Patients should not receive immunization with attenuated live vaccine within one week of study entry or during study period
Patients should not receive immunization with attenuated live vaccine within one week of study entry or during study period
Immunization with any attenuated live vaccine within  week prior to initiating protocol-indicated treatment.
Patients should not receive immunization with attenuated live vaccines within one week of study entry or during study period
Patients should not receive immunization with attenuated live vaccines within one week ( days) of study entry or during study period
Patients should not receive immunization with attenuated live vaccines =<  days of study entry or during study period
No immunizations with attenuated live vaccines within one week of study entry or during study period
Immunization with a live/attenuated vaccine within  days of enrollment
Patients should not receive immunization with attenuated live vaccines during study period or within  week of study entry
Patients should not receive immunization with attenuated live vaccines within one week of study entry or during study period
Patients must not have received immunization with an attenuated live vaccine within seven days prior to registration nor have plans to receive such vaccination while on protocol treatment
Immunization with any attenuated live vaccine within  week prior to registration
Patients should not receive immunization with attenuated live vaccines during study period
Receive immunization with attenuated live vaccines within one week of randomization or during the study period.
Patients should not receive immunization with attenuated live vaccines within one week of study entry or during study period
Immunization with a live/attenuated vaccine within  days prior to conditioning
Immunization with a live, attenuated vaccine within  weeks prior to study enrollment
